Recent Soleno-sponsored Posters and Presentations – Content provided on this page is intended for scientific exchange and may include references to, or data/information regarding a Soleno investigational product or use of a Soleno product that has not been FDA approved; no conclusions regarding the safety or efficacy can be made. Furthermore, this information should not be construed as recommendation for use of, or intent to promote a Soleno product for unapproved uses.
The content provided is intended for your personal and educational use only. Any further reproduction or distribution is not permitted without permission from the copyright owners or authors.
Presentation
European Society for Paediatric Endocrinology (ESPE 2024)
16-18 November 2024. Liverpool, UK.
Long-term Efficacy Results of Diazoxide Choline Extended-Release (DCCR) Tablets in Participants with Prader-Willi Syndrome from the Completed C601 (DESTINY PWS) and C602 Open Label Extension (OLE) Studies.
Gevers E, Bridges N, Yanovski J, et al.
